Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Top 10 HIV Clinical Developments of 2015

What is most interesting about the past year's events is how our wonderful capacity for invention and innovation is matched by our incredible and frustrating ability to screw things up. So here are both the commendable and the concerning: my top 10 stories from 2015.

Published
08 December 2015
From
The Body Pro
The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

The Medicines Patent Pool (MPP) today announced a collaboration with the University of Liverpool and a licence for the university’s Solid Drug Nanoparticle (SDN) technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines. The agreement covers a territory of all 135 low- and middle-income countries and two high-income countries in Africa, where licensees based anywhere in the world will have the right to make, use and distribute lower cost ARVs based on SDN technology.

Published
03 December 2015
From
Medicines Patent Pool
Ipergay PrEP study results published

The results from the Ipergay study of intermittent pre-exposure prophylaxis (PrEP) were published in the New England Journal of Medicine (NEJM) on 1 December, World AIDS

Published
02 December 2015
By
Gus Cairns
WHO issues recommendations on linkage to care, retention, to help bring HIV treatment to all

The World Health Organization (WHO) has issued new recommendations on how to organise services in order to promote linkage to care and retention in care as part

Published
01 December 2015
By
Keith Alcorn
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what’s new

The 2015 guidelines includes 10 new recommendations to improve the quality and efficiency of services to people living with HIV. Implementation of the recommendations in these guidelines on universal eligibility for ART will mean that more people will start ART earlier.

Published
01 December 2015
From
World Health Organization
Barriers to progress – Treatment activists’ response to WHO HIV treatment guidelines 2015

Three issues that represent barriers to continued progress: community-led treatment education is inadequately supported and needs to be scaled up; people living in middle income countries are denied affordable access to essential medicines, such as dolutegravir; availability of routine viral load monitoring remains patchy.and limited in too many countries.

Published
01 December 2015
From
International Treatment Preparedness Coalition
Three new agreements announced with the potential to expand access to innovative HIV treatment in low- and middle-income countries

The Clinton Health Access Initiative, Inc. (CHAI), UNAIDS, and UNITAID announce today three new agreements that could increase access to more sustainable HIV drug regimens at reduced prices, pending stringent regulatory approval and/or World Health Organization (WHO) pre-qualification.

Published
01 December 2015
From
UNITAID
Accelerate expansion of antiretroviral therapy to all people living with HIV: WHO

On World AIDS Day WHO emphasizes that expanding antiretroviral therapy to all people living with HIV is key to ending the AIDS epidemic within a generation.

Published
01 December 2015
From
World Health Organization
$20M Grant from amfAR Funds Institute for HIV Cure Research

With $20 million over five years, the amfAR Institute for HIV Cure Research will support the work of scientists at UC San Francisco (UCSF), the Gladstone Institute for Virology and Immunology (GIVI), the Blood Systems Research Institute (BSRI) and other academic partners who are at the forefront of the effort to cure AIDS, rather than simply treating it as a chronic disease.

Published
01 December 2015
From
UCSF News Services
Cipla ready to launch low dose HIV drug efavirenz

Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.

Published
01 December 2015
From
Economic Times

Filter by country